Company intelligence / Profile preview

Quan Capital

Shanghai, China

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Quan Capital is not a drug development company but a healthcare-focused global venture capital firm that invests in and builds early- and growth-stage life sciences companies in China and globally.[1][4][5]

Industry: Investors

Partnerships

Multiple portfolio and co-investment relationships with biotech, pharma, and healthcare companies globally and in China (as an investor and company-builder rather than a traditional corporate partnership).[1][4][5]

Beyond the preview

Go deeper on Quan Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quan Capital.

Explore the full profile